Immunotherapy in human glioblastoma

Revue Neurologique

Volumn 167, Issue 10, 2011, Pages 668-672

  Szabo, A T ^a,b   Carpentier, A F ^a,b  

^a AVICENNE HOSPITAL   (France)

^b UNIVERSITÉ PARIS 13   (France)

Author keywords

Glioblastoma; Glioma; Immunotherapy; Vaccine

Indexed keywords

ANTINEOPLASTIC AGENT; ANTISENSE OLIGONUCLEOTIDE; CANCER VACCINE; CDX 110; IPILIMUMAB; TEMOZOLOMIDE; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ADOPTIVE IMMUNOTHERAPY; ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; DENDRITIC CELL; GLIOBLASTOMA; GLIOMA; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; IMMUNOTHERAPY; MELANOMA; TUMOR IMMUNITY;

ANIMALS; BRAIN NEOPLASMS; CANCER VACCINES; CLINICAL TRIALS AS TOPIC; GLIOBLASTOMA; HUMANS; IMMUNE TOLERANCE; IMMUNOTHERAPY; IMMUNOTHERAPY, ACTIVE; IMMUNOTHERAPY, ADOPTIVE;

EID: 81955160756     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurol.2011.07.002     Document Type: Article

References (48)

1. N. Ahmed, V.S. Salsman, Y. Kew, D. Shaffer, S. Powell, and Y.J. Zhang HER2-specific T cells target primary glioblastoma stem cells and induce regression of autologous experimental tumors Clin Cancer Res 16 2010 474 485
2. M.L. Albert, S.F. Pearce, L.M. Francisco, B. Sauter, P. Roy, and R.L. Silverstein Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes J Exp Med 188 1998 1359 1368 (Pubitemid 28478024)
3. M.L. Albert, M. Jegathesan, and R.B. Darnell Dendritic cell maturation is required for the cross-tolerization of CD8+ T cells Nat Immunol 2 2001 1010 1017 (Pubitemid 33069495)
4. F. Aloisi Immune function of microglia Glia 36 2001 165 179 (Pubitemid 33055905)
5. L. Bao, Q. Sun, and K.G. Lucas Rapid generation of CMV pp65-specific T cells for immunotherapy J Immunother 30 2007 557 561 (Pubitemid 46988089)
6. B. Becher, A. Prat, and J.P. Antel Brain-immune connection: immuno-regulatory properties of CNS-resident cells Glia 29 2000 293 304 (Pubitemid 30121420)
7. Bogdahn U, Oliushine VE, Parfenov VE, et al. Results of G004, a phase IIb study in recurrent glioblastoma patients with the TGF-b2 targeted compound AP 12009. J Clin Oncol 2006 ASCO Annual Meeting Proceedings;24:abstract 1553.
8. A. Bucciero, L. Vizioli, A. Giamundo, A.E. Castellano, A. Cerillo, and L. Vizioli Prognostic significance of lymphoid infiltration in cerebral malignant gliomas J Neurosurg Sci 34 1990 145 148
9. A. Carpentier, P. Metellus, R. Ursu, S. Zohar, F. Lafitte, and M. Barrié Intracerebral administration of CpG oligonucleotide for patients with recurrent glioblastoma: a phase II study Neuro Oncol 4 2010 401 408
10. D.A. Caruso, L.M. Orme, A.M. Neale, F.J. Radcliff, G.M. Amor, and W. Maixner Results of a phase 1 study utilizing monocyte-derived dendritic cells pulsed with tumor RNA in children and young adults with brain cancer Neuro-Oncology 6 2004 236 246 (Pubitemid 39136507)
11. C.S. Cobbs, L. Harkins, M. Samanta, G.Y. Gillespie, S. Bharara, and P.H. King Human cytomegalovirus infection and expression in human malignant glioma Cancer Res 62 2002 3347 3350 (Pubitemid 34651375)
12. P.Y. Dietrich, P.R. Walker, V. Schnuriger, P. Saas, G. Perrin, and M. Guillard TCR analysis reveals significant repertoire selection during in vitro lymphocyte culture Int Immunol 9 1997 1073 1083 (Pubitemid 27361750)
13. R.O. Dillman, C.M. Duma, P.M. Schiltz, C. DePriest, R.A. Ellis, and K. Okamoto Intracavitary placement of autologous lymphokine-activated killer (LAK) cells after resection of recurrent glioblastoma J Immunother 27 2004 398 404 (Pubitemid 39121929)
14. A. Facoetti, R. Nano, P. Zelini, P. Morbini, E. Benericetti, and M. Ceroni Human leukocyte antigen and antigen processing machinery component defects in astrocytic tumors Clin Cancer Res 11 2005 8304 8311 (Pubitemid 41746941)
15. P.E. Fecci, D.A. Mitchell, J.F. Whitesides, W. Xie, A.H. Friedman, and G.E. Archer Increased regulatory T-cell fraction amidst a diminished CD4 compartment explains cellular immune defects in patients with malignant glioma Cancer Res 66 2006 3294 3302
16. J.D. Fontenot, A.Y. Rudensky, and A. well-adapted regulatory contrivance: Regulatory T cell development and the forkhead family transcription factor Foxp3 Nat Immunol 6 2005 331 337
17. M. Hishii, T. Nitta, H. Ishida, M. Ebato, A. Kurosu, and H. Yagita Human glioma-derived interleukin-10 inhibits antitumor immune responses in vitro Neurosurgery 37 1995 1160 1166
18. N. Hoa, L. Ge, Y. Kuznetsov, A. McPherson, A.N. Cornforth, and J.T. Pham Glioma cells display complex cell surface topographies that resist the actions of cytolytic effector lymphocytes J Immunol 185 2010 4793 4803
19. S.F. Hussain, D. Yang, D. Suki, E. Grimm, and A.B. Heimberger Innate immune functions of microglia isolated from human glioma patients J Transl Med 4 2006 15
20. K.S. Kahlon, C. Brown, L.J. Cooper, A. Raubitschek, S.J. Forman, and M.C. Jensen Specific recognition and killing of glioblastoma multiforme by interleukin 13-zetakine redirected cytolytic T cells Cancer Res 64 2004 9160 9166 (Pubitemid 39665531)
21. C. Kjellman, S.P. Olofsson, O. Hansson, T. Von Schantz, M. Lindvall, and I. Nilsson Expression of TGF-beta isoforms. TGF-beta receptors, and SMAD molecules at different stages of human glioma Int J Cancer 89 2000 251 258 (Pubitemid 30430741)
22. S. Kusmartsev, and D.I. Gabrilovich Role of immature myeloid cells in mechanisms of immune evasion in cancer Cancer Immunol Immunother 55 2006 237 245 (Pubitemid 41683212)
23. L.M. Liau, R.M. Prins, S.M. Kiertscher, S.K. Odesa, T.J. Kremen, and A.J. Giovannone Dendritic cell vaccination in glioblastoma patients induces systemic and intracranial T-cell responses modulated by the local central nervous system tumor microenvironment Clin Cancer Res 11 2005 5515 5525 (Pubitemid 41060828)
24. B. Lin, A. Madan, J.G. Yoon, X. Fang, X. Yan, and T.K. Kim massively parallel signature sequencing and bioinformatics analysis identifies up-regulation of TGFBI and SOX4 in human glioblastoma Plos One 5 2010 e10210
25. R.E. Merchant, A.J. Grant, L.H. Merchant, and H.F. Young Adoptive immunotherapy for recurrent glioblastoma multiforme using lymphokine activated killer cells and recombinant interleukin-2 Cancer 62 1988 665 671
26. D.A. Mitchell, W. Xie, R. Schmittling, C. Learn, A. Friedman, and R.E. McLendon Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma Neuro Oncol 10 2008 10 18 (Pubitemid 351250896)
27. H. Okada, P. Kalinski, R. Ueda, A. Hoji, G. Kohanbash, and T.E. Donegan Induction of CD8+ T-cell responses against novel glioma-associated antigen peptides and clinical activity by vaccinations with {alpha}-type 1 polarized dendritic cells and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in patients with recurrent malignant glioma J Clin Oncol 29 2011 330 336
28. W.W. Overwijk, M.R. Theoret, S.E. Finkelstein, D.R. Surman, L.A. de Jong, and F.A. Vyth-Dreese Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells J Exp Med 198 2003 569 580 (Pubitemid 37040391)
29. K.B. Quattrocchi, C.H. Miller, S. Cush, S.A. Bernard, S.T. Dull, and M. Smith Pilot study of local autologous tumor infiltrating lymphocytes for the treatment of recurrent malignant gliomas J Neuro-Oncol 45 1999 141 157 (Pubitemid 30197728)
30. D.M. Pardoll, and S.L. Topalian The role of CD4+ T cell responses in antitumor immunity Curr Opin Immunol 10 1998 588 594 (Pubitemid 28479193)
31. I.F. Parney, L.J. Chang, M.A. Farr-Jones, C. Hao, M. Smylie, and K.C. Petruk Technical hurdles in a pilot clinical trial of combined B7-2 and GM-CSF immunogene therapy for glioblastomas and melanomas J Neurooncol 78 2006 71 80 (Pubitemid 43786663)
32. G.E. Plautz, D.W. Miller, G.H. Barnett, G.H. Stevens, S. Maffett, and J. Kim T cell adoptive immunotherapy of newly diagnosed gliomas Clin Cancer Res 6 2000 2209 2218 (Pubitemid 30399186)
33. Polisetty RV, Gupta MK, Sudha C. Nair, Ramamoorthy K, Tiwary S, et al. Glioblastoma cell secretome: analysis of three glioblastoma cell lines reveal 148 non-redundant proteins. J Proteomics 2011 in press.
34. R.M. Prins, H. Soto, V. Konkankit, S.K. Odesa, A. Eskin, and W.H. Yong Gene expression profile correlates with T-cell infiltration and relative survival in glioblastoma patients vaccinated with dendritic cell immunotherapy Clin Cancer Res 17 2011 1603 1615
35. P.C. Rodriguez, C.P. Hernandez, D. Quiceno, S.M. Dubinett, J. Zabaleta, and J.B. Ochoa Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma J Exp Med 202 2005 931 939 (Pubitemid 41396893)
36. M.E. Scheurer, M.L. Bondy, K.D. Aldape, T. Albrecht, and R. El-Zein Detection of human cytomegalovirus in different histological types of gliomas Acta Neuropathol 116 2008 79 86
37. K. Staveley-O'Carroll, E. Sotomayor, J. Montgomery, I. Borrello, L. Hwang, and S. Fein Induction of antigen-specific T cell anergy: an early event in the course of tumor progression Proc Natl Acad Sci USA 95 1998 1178 1183 (Pubitemid 28124932)
38. H.H. Steiner, M.M. Bonsanto, P. Beckhove, M. Brysch, K. Geletneky, and R. Ahmadi Antitumor vaccination of patients with glioblastoma multiforme: a pilot study to assess feasibility, safety, and clinical benefit J Clin Oncol 22 2004 4272 4281 (Pubitemid 41185148)
39. R. Stupp, W.P. Mason, M.J. van den Bent, M. Weller, B. Fisher, and M. Taphoorn Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma N Engl J Med 352 2005 987 996 (Pubitemid 40349501)
40. J. Tang, P. Flomenberg, L. Harshyne, L. Kenyon, and D.W. Andrews Glioblastoma patients exhibit circulating tumor-specific CD8+ T cells Clin Cancer Res 1 2005 5292 5299 (Pubitemid 41003718)
41. K. Tsuboi, K. Saijo, E. Ishikawa, H. Tsurushima, S. Takano, and Y. Morishita Effects of local injection of ex vivo expanded autologous tumor-specific T lymphocytes in cases with recurrent malignant gliomas Clin Cancer Res 9 2003 3294 3302 (Pubitemid 37082723)
42. R. Ueda, G. Kohanbash, K. Sasaki, M. Fujita, X. Zhu, and E.R. Kastenhuber Dicer-regulated microRNAs 222 and 339 promote resistance of cancer cells to cytotoxic T-lymphocytes by down-regulation of ICAM-1 Proc Natl Acad Sci U S A 106 2009 10746 10751
43. J.J. Watters, J.M. Schartner, and B. Badie Microglia function in brain tumors J Neurosci Res 81 2005 447 455 (Pubitemid 41359299)
44. J.D. Wolchok, B. Neyns, G. Linette, S. Negrier, J. Lutzky, and L. Thomas Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study Lancet Oncol 11 2010 155 164
45. N. Yajima, R. Yamanaka, T. Mine, N. Tsuchiya, J. Homma, and M. Sano Immunologic evaluation of personalized peptide vaccination for patients with advanced malignant glioma Clin Cancer Res 11 2005 5900 5911 (Pubitemid 41170319)
46. R. Yamanaka, J. Homma, N. Yajima, N. Tsuchiya, M. Sano, and T. Kobayashi Clinical evaluation of dendritic cell vaccination for patients with recurrent glioma: results of a clinical phase I/II trial Clin Cancer Res 11 2005 4160 4167 (Pubitemid 40791581)
47. J.S. Yu, G. Liu, H. Ying, W.H. Yong, K.L. Black, and C.J. Wheeler Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma Cancer Res 64 2004 4973 4979 (Pubitemid 38924545)
48. J.G. Zhang, J. Eguchi, C.A. Kruse, G.G. Gomez, H. Fakhrai, and S. Schroter Antigenic profiling of glioma cells to generate allogeneic vaccines or dendritic cell-based therapeutics Clin Cancer Res 13 2007 566 575 (Pubitemid 46225363)